By: Saurabh
Cancer Vaccine
Russia has announced the development of an mRNA-based cancer vaccine. It will be distributed for free to patients and is expected to be available by early 2025.
The vaccine was created in collaboration with multiple research centers. Preclinical trials demonstrate its ability to suppress tumor growth and potential metastases.
Cancer is a leading cause of death globally, causing nearly 10 million deaths in 2020. Common cancers include breast, lung, colon, rectum, and prostate cancers.
Global Impact
One-third of cancer deaths are linked to lifestyle factors like smoking, obesity, alcohol use, poor diet, and lack of exercise. Air pollution is also a significant risk factor for lung cancer.
mRNA vaccines instruct cells to produce proteins similar to those of a disease-causing agent, triggering an immune response. They are a promising technology for personalized treatments.
mRNA Explained
AI, particularly artificial neural networks, can reduce the time required to compute personalized mRNA vaccines from days to under an hour, expediting vaccine development, TASS reported.
AI in Cancer Vaccine
With AI and advanced medical research, personalized cancer vaccines could revolutionize treatment. Russia's mRNA cancer vaccine marks a significant step forward in oncology.
Future Prospects